NCT01164397|Completed
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · AstraZeneca
observational
268
1 country
9
Study Start
April 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
December 2010
Actual (reported)The aim of this study is to evaluate the effectiveness of Rosuvastatin versus Ezetimibe/Simvastatin in dyslipidemic patients treated for at least 8 weeks.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2010
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2009
Date type not reportedThis date has not been verified as actual or estimated.
May 28, 2010
Actual (reported)July 16, 2010
Actual (reported)December 2010
Actual (reported)The percentage of the patients that achieve the goal proposed for NCEP ATP III (2001 y 2004) will be assessed, to C-LDL in patients treated with Rosuvastatin or Ezetimibe/Simvastatin at least for 8 weeks.
Data will be collected using CRFs after complete at least 15 patients over a 24 week period.
The percentage of LDL-C reduction according to baseline levels in patients treated wuth Rosuvastatin or Ezetimibe/Simvastatin for at least 8 weeks.
Data will be collected using CRFs after complete at least 15 patients over a 24 week period.
People with high levels of total cholesterol, LDL, C-HDL and triglycerides
Care clinic private practice
Research Site
Guadalajara, Jalisco, Mexico
Research Site
Mexico City, Mexico City, Mexico
Research Site
Cuernavaca, Morelos, Mexico
Research Site
Monterrey, Nuevo León, Mexico
Research Site
Puebla City, Puebla, Mexico
Research Site
San Luis Potosí City, San Luis Potosí, Mexico
Research Site
Veracruz, Xalapa, Mexico
Ana Polanco, MD
AstraZeneca
268 participants (actual enrollment reported by the registry).
First Submitted
May 28, 2010
First Posted
July 16, 2010
Study Start
April 2009
Date type not reportedThis date has not been verified as actual or estimated.
Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia
Contact the study team to confirm eligibility.
Research Site
Mérida, Yucatán, Mexico
Research Site
Durango, Mexico
Study Completion
December 2010
Actual (reported)Last Updated
January 18, 2012
Record last verified: 2012-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: